UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Management of patent ductus arteriosus in premature infants

Medychni perspektyvy, 2019-01, Vol.24 (2), p.33-40

2019

Volltextzugriff (PDF)

Injection drug users' perceptions of drug treatment services and attitudes toward substitution therapy: A qualitative study in three Russian cities

Journal of substance abuse treatment, 2007-12, Vol.33 (4), p.373-378

2007

Volltextzugriff (PDF)

Modern aspects of diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy in children

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2024, Vol.124 (2), p.58

2024

Volltextzugriff (PDF)

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

Annals of oncology, 2003-09, Vol.14 (9), p.1399-1405

2003

Volltextzugriff (PDF)

Secondary prevention of patients with ischaemic stroke after recanalization treatment

EUROPEAN PHARMACEUTICAL JOURNAL, 2022-07, Vol.69 (s1), p.79-81

2022

Volltextzugriff (PDF)

A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate

Annals of the rheumatic diseases, 2012-07, Vol.71 (7), p.1183-1189

2012

Volltextzugriff (PDF)

Pelotherapy and pelotherapy combined with intravenous laser blood irradiation at the sanatorium-resort stage of treatment of patients with psoriasis vulgaris

Voprosy kurortologii, fizioterapii i lečebnoj fizičeskoj kulʹtury, 2024, Vol.101 (2), p.24

2024

Volltextzugriff (PDF)

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial

Annals of oncology, 2006-02, Vol.17 (2), p.289-296

2006

Volltextzugriff (PDF)

Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2023, Vol.123 (4), p.37

2023

Volltextzugriff (PDF)

Antiviral Properties, Metabolism, and Pharmacokinetics of a Novel Azolo-1,2,4-Triazine-Derived Inhibitor of Influenza A and B Virus Replication

Antimicrobial Agents and Chemotherapy, 2010-05, Vol.54 (5), p.2017-2022

2010

Volltextzugriff (PDF)

Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia

International journal of gynecology and obstetrics, 2008-04, Vol.101 (1), p.67-73

2008

Volltextzugriff (PDF)

Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats

Journal of drug targeting, 2006-01, Vol.14 (2), p.97-105

2006

Volltextzugriff (PDF)

Parvovirus B19 infection in HIV-infected patients

Terapevtic̆eskii arhiv, 2020-09, Vol.92 (7), p.100

2020

Volltextzugriff (PDF)

Results of a phase 1 clinical study of anti-CD20 monoclonal antibody (BCD-132): pharmacokinetics, pharmacodynamics and safety

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2019, Vol.119 (10. Vyp. 2), p.87

2019

Volltextzugriff (PDF)

Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model

Journal of microencapsulation, 2006-08, Vol.23 (5), p.582-592

2006

Volltextzugriff (PDF)

A place of intravenous immunoglobulins in current clinical practice: Privigen is a novel 10% immunoglobulin

Terapevtic̆eskii arhiv, 2016-01, Vol.88 (4), p.82

2016

Volltextzugriff (PDF)

The efficacy of remaxol addition in the treatment of alcohol withdrawal syndrome

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2016, Vol.116 (1), p.40

2016

Volltextzugriff (PDF)

Effects of Long-Term Intravenous Ibandronate Therapy on Skeletal-Related Events, Survival, and Bone Resorption Markers in Patients With Advanced Multiple Myeloma

Journal of clinical oncology, 2002-05, Vol.20 (9), p.2353-2359

2002

Volltextzugriff (PDF)

Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women

Annals of the rheumatic diseases, 2003-10, Vol.62 (10), p.969-975

2003

Volltextzugriff (PDF)

A COMPARISON OF TWO APPROACHES FOR INTRAOPERATIVE LEVOSIMENDAN ADMINISTRATION IN CARDIAC SURGICAL PATIENTS WITH SEVERE LEFT VENTRICLE DYSFUNCTION.

Anesteziologiia i reanimatologiia, 2016-09, Vol.61 (5), p.334

2016

Volltextzugriff (PDF)

The study of the efficacy and safety of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2019, Vol.119 (12. Vyp. 2), p.89

2019

Volltextzugriff (PDF)

Intravenous immunoglobulin in treatment of autoimmune neurological diseases in children

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2015, Vol.115 (8), p.83

2015

Volltextzugriff (PDF)

The efficacy of intravenous lacosamide in psychiatric hospital

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2016, Vol.116 (2), p.67

2016

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Aktive Filter

SpracheSerbian

ThemaAged

SpracheEnglisch

SpracheRussisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(49)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management of patent ductus arteriosus in premature infants

Injection drug users' perceptions of drug treatment services and attitudes toward substitution therapy: A qualitative study in three Russian cities

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial

Modern aspects of diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy in children

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

Secondary prevention of patients with ischaemic stroke after recanalization treatment

A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate

Pelotherapy and pelotherapy combined with intravenous laser blood irradiation at the sanatorium-resort stage of treatment of patients with psoriasis vulgaris

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial

Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2

Antiviral Properties, Metabolism, and Pharmacokinetics of a Novel Azolo-1,2,4-Triazine-Derived Inhibitor of Influenza A and B Virus Replication

Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia

Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats

Parvovirus B19 infection in HIV-infected patients

Results of a phase 1 clinical study of anti-CD20 monoclonal antibody (BCD-132): pharmacokinetics, pharmacodynamics and safety

Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model

A place of intravenous immunoglobulins in current clinical practice: Privigen is a novel 10% immunoglobulin

The efficacy of remaxol addition in the treatment of alcohol withdrawal syndrome

Effects of Long-Term Intravenous Ibandronate Therapy on Skeletal-Related Events, Survival, and Bone Resorption Markers in Patients With Advanced Multiple Myeloma

Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women

A COMPARISON OF TWO APPROACHES FOR INTRAOPERATIVE LEVOSIMENDAN ADMINISTRATION IN CARDIAC SURGICAL PATIENTS WITH SEVERE LEFT VENTRICLE DYSFUNCTION.

The study of the efficacy and safety of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia

Intravenous immunoglobulin in treatment of autoimmune neurological diseases in children

The efficacy of intravenous lacosamide in psychiatric hospital

Aktive Filter

Suchergebnisse filtern